Results 21 to 30 of about 250,250 (265)

Effects of Peripheral Blood Mononuclear Cell Administration on Wound Healing in Rats with Experimental Diabetes

open access: yesVan Tıp Dergisi, 2021
INTRODUCTION: Treatment of diabetic wounds is a difficult and costly condition that reduces the patient's quality of life. In this area, cell therapies have taken their place in clinical use.
Pınar Kılıçaslan Sönmez   +1 more
doaj   +1 more source

CPEB4 and IRF4 expression in peripheral mononuclear cells are potential prognostic factors for advanced lung cancer

open access: yesJournal of the Formosan Medical Association, 2017
Lung cancer is a heterogeneous disease with varied outcomes. Molecular markers are eagerly investigated to predict a patient's treatment response or outcome. Previous studies used frozen biopsy tissues to identify crucial genes as prognostic markers.
Yi-Ying Wu   +8 more
doaj   +1 more source

The Effects of Sodium Acetate on the Immune Functions of Peripheral Mononuclear Cells and Polymorphonuclear Granulocytes in Postpartum Dairy Cows

open access: yesAnimals, 2023
Excessive lipid mobilization will snatch cell membrane lipids in postpartum dairy cows, which may impair the function of immune cells, including peripheral mononuclear cells (PBMCs) and polymorphonuclear granulocytes (PMNs).
Cong Yuan   +6 more
doaj   +1 more source

Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligand administration

open access: yesHaematologica, 2010
Background Flt3-ligand is a cytokine that induces relatively slow mobilization of hematopoietic cells in animals and humans in vivo. This provides a time-frame to study hematopoietic stem and progenitor cell migration kinetics in detail.Design and ...
Evert-Jan F.M. de Kruijf   +4 more
doaj   +1 more source

Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab

open access: yesHaematologica, 2011
Background In our efforts to develop novel effective treatment regimens for multiple myeloma we evaluated the potential benefits of combining the immunomodulatory drug lenalidomide with daratumumab.
Michael. S. van der Veer   +7 more
doaj   +1 more source

Use of a commercial feed supplement based on yeast products and microalgae with or without nucleotide addition in calves

open access: yesJournal of Dairy Science, 2023
: The use of feed additives with antioxidant and immune response modulatory activity could be a useful strategy in suckling calves to reduce morbidity and mortality. This strategy is based on several feed additives tested for these purposes.
Aristide Maggiolino   +10 more
doaj   +1 more source

Strategy to prime the host and cells to augment therapeutic efficacy of progenitor cells for patients with myocardial infarction

open access: yesFrontiers in Cardiovascular Medicine, 2016
Cell therapy in myocardial infarction (MI) is an innovative strategy that is regarded as a rescue therapy to repair the damaged myocardium and to promote neovascularization for the ischemic border zone.
Jeehoon Kang   +7 more
doaj   +1 more source

Integrity of genome-wide genotype data from low passage lymphoblastoid cell lines

open access: yesGenomics Data, 2016
We compared genotype data from the HumanExomeCore Array in peripheral blood mononuclear cells and low passage lymphoblastoid cell lines from the same 24 individuals to test for genotypic errors caused by the Epstein–Barr Virus transformation process ...
Nina S. McCarthy   +4 more
doaj   +1 more source

Autologous peripheral blood mononuclear cells for the treatment of lower extremity lymphedema: preliminary results

open access: yesVeins and Lymphatics, 2021
Lymphedema is a chronic devastating disease characterized by the accumulation of fluid in the extremities, tissue progressive changes such as adipose tissue deposition and fibrosis.
Mario Bellisi
doaj   +1 more source

Organoids in pediatric cancer research

open access: yesFEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

Home - About - Disclaimer - Privacy